AR078181A1 - Derivados acetilenicos de 5-fenilpirazolopiridina, su preparacion y su aplicacion terapeutica en enfermedades mediadas por los receptores nucleares nurr-1 - Google Patents
Derivados acetilenicos de 5-fenilpirazolopiridina, su preparacion y su aplicacion terapeutica en enfermedades mediadas por los receptores nucleares nurr-1Info
- Publication number
- AR078181A1 AR078181A1 ARP100103376A ARP100103376A AR078181A1 AR 078181 A1 AR078181 A1 AR 078181A1 AR P100103376 A ARP100103376 A AR P100103376A AR P100103376 A ARP100103376 A AR P100103376A AR 078181 A1 AR078181 A1 AR 078181A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylpirazolopiridine
- nurlear
- acetilenic
- derivatives
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos de formula (1): en la que: R1 y R2 representan, independientemente entre sí, un átomo de hidrogeno o un grupo alquilo C1-6; R3 representa uno o varios átomos de hidrogeno o de halogeno. X representa de 1 a 4 sustituyentes idénticos o diferentes entre sí elegidos entre hidrogeno, halogeno o alquilo C1-6, en el estado de base o de sal de adicion a un ácido. Uso en terapia y procedimiento de síntesis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0956445A FR2950345B1 (fr) | 2009-09-18 | 2009-09-18 | Derives acetyleniques de 5-phenyl-pyrazolopyridine, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AR078181A1 true AR078181A1 (es) | 2011-10-19 |
Family
ID=42244672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100103376A AR078181A1 (es) | 2009-09-18 | 2010-09-16 | Derivados acetilenicos de 5-fenilpirazolopiridina, su preparacion y su aplicacion terapeutica en enfermedades mediadas por los receptores nucleares nurr-1 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8546424B2 (es) |
EP (1) | EP2477988B1 (es) |
JP (1) | JP5616452B2 (es) |
AR (1) | AR078181A1 (es) |
FR (1) | FR2950345B1 (es) |
JO (1) | JO2951B1 (es) |
TW (1) | TWI458728B (es) |
UY (1) | UY32895A (es) |
WO (1) | WO2011033229A1 (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003531906A (ja) * | 2000-04-28 | 2003-10-28 | グラクソ グループ リミテッド | ピラゾロピリジン誘導体の製造方法 |
NZ529333A (en) * | 2001-04-27 | 2005-01-28 | Eisai Co Ltd | Pyrazolo[1,5-a]pyridines and medicines containing the same |
US7365066B2 (en) * | 2002-09-17 | 2008-04-29 | Eli Lilly And Company | Pyrazolopyridine derivatives as pharmaceutical agents |
FR2906250B1 (fr) * | 2006-09-22 | 2008-10-31 | Sanofi Aventis Sa | Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique |
AR064491A1 (es) * | 2006-12-22 | 2009-04-08 | Astex Therapeutics Ltd | Derivados de imidazo[1, 2-a]pirimidina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por las quinasas fgfr. |
JP5442449B2 (ja) * | 2006-12-22 | 2014-03-12 | アステックス、セラピューティックス、リミテッド | 新規化合物 |
FR2928922B1 (fr) * | 2008-03-21 | 2010-04-23 | Sanofi Aventis | Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique |
FR2953520B1 (fr) * | 2009-12-04 | 2011-11-25 | Sanofi Aventis | Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique |
-
2009
- 2009-09-18 FR FR0956445A patent/FR2950345B1/fr not_active Expired - Fee Related
-
2010
- 2010-09-16 AR ARP100103376A patent/AR078181A1/es unknown
- 2010-09-16 JO JO2010316A patent/JO2951B1/en active
- 2010-09-17 JP JP2012529328A patent/JP5616452B2/ja not_active Expired - Fee Related
- 2010-09-17 WO PCT/FR2010/051931 patent/WO2011033229A1/fr active Application Filing
- 2010-09-17 UY UY0001032895A patent/UY32895A/es not_active Application Discontinuation
- 2010-09-17 TW TW099131735A patent/TWI458728B/zh not_active IP Right Cessation
- 2010-09-17 US US13/395,819 patent/US8546424B2/en not_active Expired - Fee Related
- 2010-09-17 EP EP10770577.4A patent/EP2477988B1/fr not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
FR2950345B1 (fr) | 2011-09-23 |
EP2477988B1 (fr) | 2013-07-17 |
FR2950345A1 (fr) | 2011-03-25 |
JP5616452B2 (ja) | 2014-10-29 |
TWI458728B (zh) | 2014-11-01 |
JP2013505226A (ja) | 2013-02-14 |
US8546424B2 (en) | 2013-10-01 |
EP2477988A1 (fr) | 2012-07-25 |
TW201116529A (en) | 2011-05-16 |
WO2011033229A1 (fr) | 2011-03-24 |
JO2951B1 (en) | 2016-03-15 |
US20120270897A1 (en) | 2012-10-25 |
UY32895A (es) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31730A (es) | Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica. | |
CO6551713A2 (es) | Derivados de difenil -pirazolopiridinas, su preparación y su aplicación como moduladores del receptor nuclear not | |
UY31606A1 (es) | Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica | |
ECSP099216A (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CU20110204A7 (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
UY31608A1 (es) | Derivados de carboxamidas n-azabicíclicas, su preparación y su aplicación en terapéutica | |
AR060535A1 (es) | Pirido-piridazinonas y ftalazinonas como antagonistas duales de los receptores h1 y h3 de histamina | |
AR088226A1 (es) | Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas | |
UY31906A (es) | Derivados de n-cicloalquil-3-fenilnicotinamida que inhiben pgds, sus composiciones, su uso para el tratamiento por ejemplo de afecciones alérgicas y respiratorias. | |
EA201201052A1 (ru) | Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk | |
CU24030B1 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
AR077534A1 (es) | Derivados de isoxazol, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades relacionadas con el receptor gaba aalfa5 | |
NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
AR070485A1 (es) | Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica | |
CO6341634A2 (es) | Nuevos derivados de imidazo(1,2-a)pirimidina, su procesamiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion particularmente como inhibidores de met | |
AR073043A1 (es) | Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras. | |
UY32635A (es) | Derivados de bis-(sulfonilamino) en terapia 735 | |
PE20141527A1 (es) | Derivados de 2-amino-3-(imidazol-2-il)-piridin-4-ona, preparacion de los mismos y su uso terapeutico de los mismos | |
AR083492A1 (es) | Derivados aminicos para el tratamiento de trastornos proliferativos de la piel | |
ECSP099679A (es) | Nuevos compuestos y sus usos 707 | |
UY31587A1 (es) | Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica. | |
UY31589A1 (es) | Derivados 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica | |
UY32894A (es) | Derivados de 5-fenil-pirazolopiridina, su preparación y su aplicación en terapéutica | |
AR078181A1 (es) | Derivados acetilenicos de 5-fenilpirazolopiridina, su preparacion y su aplicacion terapeutica en enfermedades mediadas por los receptores nucleares nurr-1 | |
UY31586A1 (es) | Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |